Australian Clinical Labs Ltd (ACL) — Capital Reinvestment Ratio
Latest as of December 2025:
0.06x
Australian Clinical Labs Ltd (ACL) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$62.87 Million) in capital expenditures (AU$3.47 Million). See Australian Clinical Labs Ltd (ACL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
AU$62.87 Million
AUD
Capital Expenditures
AU$3.47 Million
AUD
Data as of
Dec 2025
Most recent filing
Australian Clinical Labs Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Australian Clinical Labs Ltd's Capital Reinvestment Ratio across 18 annual periods.
Annual Capital Reinvestment Ratio for Australian Clinical Labs Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Australian Clinical Labs Ltd from 2016 to 2025. For live market cap and broader valuation context, see market cap of Australian Clinical Labs Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | AU$182.80 Million | AU$8.41 Million | ▲ +0.0% |
| 2024 | 0.05x | AU$182.80 Million | AU$8.41 Million | ▲ +12.9% |
| 2024 | 0.04x | AU$159.59 Million | AU$6.50 Million | ▲ +0.0% |
| 2023 | 0.04x | AU$159.59 Million | AU$6.50 Million | ▼ -15.5% |
| 2023 | 0.05x | AU$143.68 Million | AU$6.93 Million | ▲ +0.0% |
| 2022 | 0.05x | AU$143.68 Million | AU$6.93 Million | ▼ -35.5% |
| 2022 | 0.07x | AU$284.09 Million | AU$21.25 Million | ▲ +0.0% |
| 2021 | 0.07x | AU$284.09 Million | AU$21.25 Million | ▲ +21.1% |
| 2021 | 0.06x | AU$153.86 Million | AU$9.51 Million | ▲ +0.0% |
| 2020 | 0.06x | AU$153.86 Million | AU$9.51 Million | ▼ -33.0% |
| 2020 | 0.09x | AU$101.74 Million | AU$9.38 Million | ▲ +0.0% |
| 2019 | 0.09x | AU$101.74 Million | AU$9.38 Million | ▼ -99.3% |
| 2019 | 12.92x | AU$1.11 Million | AU$14.36 Million | ▲ +0.0% |
| 2018 | 12.92x | AU$1.11 Million | AU$14.36 Million | ▲ +601.9% |
| 2018 | 1.84x | AU$4.69 Million | AU$8.63 Million | ▲ +0.0% |
| 2017 | 1.84x | AU$4.69 Million | AU$8.63 Million | ▲ +13.6% |
| 2017 | 1.62x | AU$4.60 Million | AU$7.46 Million | ▲ +0.0% |
| 2016 | 1.62x | AU$4.60 Million | AU$7.46 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow